Zu den Deals
Gesundheitswesen

Cellply srl has obtained a grant by the European Commission to support its R&D program

Cellply has obtained a grant by the European Commission to support its R&D program. It is the largest one among the nine Italian companies funded in the last SME Instrument call and one of the largest at EU level since the start of the SME Instrument program in 2014. This will provide the resources to complete the development of an innovative diagnostic platform.

Cellply, based in Bologna, Italy, was founded in 2013 by two engineers, Professor Roberto Guerrieri from the University of Bologna and Massimo Bocchi. It is a medtech start-up company specialized in in vitro diagnostic systems aiming at supporting personalized oncology treatments. In 2014, the company started the development of an in vitro diagnostic platform which enabled the isolation of a tiny amount of live tumor cells sampled from patients within 20,000 microwells and to analyze the action of multiple drugs in parallel by means of proprietary algorithms to predict the response of the patient to candidate drug therapies.

Oaklins' team in Italy successfully assisted Cellply along the entire fundraising process.

Services
Funding, debt advisory & ECM
Parteien

Sprechen Sie mit dem Deal-Team

 Federico  Cappa

Federico Cappa

Partner

Mailand, Italien
Oaklins Italy
 Marco  Mobrici

Marco Mobrici

Director

Mailand, Italien
Oaklins Italy

Relevante Transaktionen

Dutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy
Private Equity | Gesundheitswesen

Dutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy

Dutch Dental Group (DDG) has raised a new debt financing package provided by ING Bank, consisting of term loans, an acquisition facility and an RCF.

Weitere Informationen
Groupe Voie Lactée has been acquired by Initiative & Finance
Private Equity | Gesundheitswesen

Groupe Voie Lactée has been acquired by Initiative & Finance

JFC Industrie has sold Groupe Voie Lactée to Initiative & Finance.

Weitere Informationen
Sonovia has raised US$10 million through an IPO
Gesundheitswesen

Sonovia has raised US$10 million through an IPO

Sonovia Ltd. has raised funds to refinance and develop the company.

Weitere Informationen